Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Operating Margin: 2020-2025

Historic Operating Margin for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -98.56%.

  • Maravai Lifesciences Holdings' Operating Margin rose 14137.00% to -98.56% in Q3 2025 from the same period last year, while for Sep 2025 it was -100.90%, marking a year-over-year decrease of 2681.00%. This contributed to the annual value of -90.91% for FY2024, which is 7995.00% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Operating Margin stood at -98.56% for Q3 2025, which was up 29.52% from -139.84% recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Operating Margin registered a high of 75.87% during Q3 2021, and its lowest value of -239.93% during Q3 2024.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Operating Margin value was -29.39% (recorded in 2024), while the average stood at -67.73%.
  • In the last 5 years, Maravai Lifesciences Holdings' Operating Margin plummeted by 21,688bps in 2024 and then soared by 14,137bps in 2025.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Operating Margin stood at 67.65% in 2021, then crashed by 1,428bps to 53.37% in 2022, then tumbled by 6,301bps to -9.64% in 2023, then crashed by 5,702bps to -66.66% in 2024, then soared by 14,137bps to -98.56% in 2025.
  • Its Operating Margin was -98.56% in Q3 2025, compared to -139.84% in Q2 2025 and -104.93% in Q1 2025.